Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simplified Insulin Regimen in Elderly T2DM
NCT03660553Phase 4Terminated
- Sponsor
- University of Miami
- Start
- Oct 2018
- Primary completion
- Jun 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin glargine in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by University of Miami. Primary endpoint: Hemoglobin A1c at 6 months. Started Oct 2018; status: terminated.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03660553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03660553.